APA (7th ed.) Citation

S, R., TA, G., A, R., K, Q., E, G., AB, H., . . . MM, P. (2025). Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm. Blood neoplasia, 2(3), 100085. https://doi.org/10.1016/j.bneo.2025.100085

Chicago Style (17th ed.) Citation

S, Raychaudhuri, et al. "Phase 1 Trial of Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone for AML and High-grade Myeloid Neoplasm." Blood Neoplasia 2, no. 3 (2025): 100085. https://doi.org/10.1016/j.bneo.2025.100085.

MLA (9th ed.) Citation

S, Raychaudhuri, et al. "Phase 1 Trial of Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone for AML and High-grade Myeloid Neoplasm." Blood Neoplasia, vol. 2, no. 3, 2025, p. 100085, https://doi.org/10.1016/j.bneo.2025.100085.